Tom RiceBuy
InMode ltd. - Ordinary shares · Transaction Nov 15, 2019 · Filed Nov 19, 2019 · $1,001 to $15,000
NASDAQ NMS - GLOBAL MARKET · INMD
0.00% · $0.0000 · Vol Not reported
Market closed · last close shown
Inmode Ltd
Health Care
$14.35
Follow $INMD
One email when a member of Congress discloses a trade in it, with the official filing receipt linked.
Free. No account. Unsubscribe in one click.
Follow $INMD by emailVeridion Score
BETAMEDIUM CONF · 6 of 6 factors measuredFri Sep 18 · last completed session · Pre-market · regular session opens 9:30 ET · INMD
MethodologyINMD
Inmode Ltd
Fri Sep 18 · last completed session · Pre-market · regular session opens 9:30 ET
Upper range
Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.
Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
64/ 100
Veridion Score
Upper range · MEDIUM confidence · 6 of 6 factors measured
Sovereign · $25/mo
See why this score moved.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: MEDIUM · 6 of 6 factors measured · Fri Sep 18 · last completed session · Pre-market · regular session opens 9:30 ET
Veridion Score History · 90D
Loading score history
AI Analysis
SovereignWhy is INMD moving today?
Sovereign unlock connects news, insider activity, analyst moves, and live price action.
About Inmode Ltd
Health CareListed since
2019
Employees
660
Country
IL
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF, and Morpheus8, among others. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia, Israel, and other regions.
Key statistics
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Open
$14.35
Last session
Day high
$14.35
Last session
Day low
$14.35
Last session
Previous close
$14.35
52W high
$16.62
-13.66% from high
52W low
$12.76
41% of range
Market cap
$825.8M
P/E
10.64×
EPS
$1.23
Beta
0.39
Shares out
57.5M
Avg volume
487.2K
VWAP
$14.35
Last session
Price history computed in-house
1W
-3.63%
1M
-4.71%
3M
+7.49%
1Y
-2.38%
YTD
-2.31%
SMA 50 $15.07 · below
SMA 200 $14.40 · below
52W position 41%
INMD overview
Related filings and maps
Public disclosures
Congress activity in INMD
Official filing ↗
Federal contracts
INMD contract awards, year to date.
Public federal awards linked to this ticker.
Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for INMD in this window.
Lobbying spend
INMD lobbying filings, year to date.
Registered lobbying filings matched to Inmode Ltd.
Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for INMD in this window.
Analyst ratings
Sovereign unlock shows live analyst consensus for INMD.
Options
Sovereign unlock shows live options positioning for INMD.